Table 6.
Imaging analysis at the end of therapy
| Results | Experimental group (%) | Control group (%) | Statistics | P |
|---|---|---|---|---|
| Focus | ||||
| Significantly absorbed | 46 (18.25) | 50 (19.38) | -0.038 | 0.970 |
| Absorbed | 197 (78.17) | 195 (75.58) | ||
| Unchanged | 9 (3.57) | 11 (4.26) | ||
| Deteriorated | 0 (0.00) | 2 (0.78) | ||
| Determined | 252 | 258 | ||
| Undetermined | 25 | 33 | ||
| Cavity | ||||
| Closed | 50 (39.27) | 52 (40.63) | 0.501 | 0.616 |
| Unchanged | 6 (4.72) | 11 (8.59) | ||
| Reduced | 71 (55.91) | 64 (50.00) | ||
| Enlarged | 0 (0.00) | 1 (0.78) | ||
| Determined | 127 | 128 | ||
| Undetermined | 150 | 163 |
Note: The groups were compared using the Wilcoxon test.